Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods.
Propolis exhibits antimicrobial, anti-inflammatory and other biological effects. The aim of this study was to evaluate the activity of 30 % ethanolic extract of Bulgarian propolis against 94 Helicobacter pylori strains by three methods. By the agar-well diffusion method, only 13.8 % of the strains exhibited no inhibition by 30 microl propolis extract (containing 9 mg propolis) and all isolates were inhibited to some extent by 90 microl of the extract (27 mg propolis) per well. The mean diameters of growth inhibition by 30, 60 or 90 microl propolis extract or 30 microl 96 % ethanol per well were 16.8, 19.2, 27.5 and 8.3 mm, respectively. The propolis extract was more active than the ethanol (P < 0.001). With 90 microl propolis extract per well, 69.4 % of the strains exhibited large diameters of growth inhibition (> or =20 mm) versus 26.6 % with 30 mul per well (P < 0.001). With moist propolis discs, inhibition was detected in more strains (92.1 %) than with dried discs (78.2 %, P < 0.05), with mean inhibitory diameters of 18.7 and 13.8 mm, respectively. By the agar dilution method, 100 and 300 microg propolis ml(-1) inhibited the growth of 57.1 % and 76.2 %, respectively, of the 21 strains tested. In conclusion, Bulgarian propolis had a strong and dose-dependent activity against most of the H. pylori strains tested. Although the effect of propolis on H. pylori in vitro is promising, further microbiological, pharmacological and clinical trials are required.
Boyanova
Lyudmila
L
Department of Microbiology, Medical University of Sofia, Zdrave Street 2, 1431 Sofia, Bulgaria 2Department of Gastroenterology, St Ivan Rilski Hospital, Bulgaria 3Department of Gastroenterology, Pediatric Hospital, Bulgaria 4Alexander Hospital, Second Surgery Hospital, Sofia, Bulgaria.
Gergova
Galina
G
Department of Microbiology, Medical University of Sofia, Zdrave Street 2, 1431 Sofia, Bulgaria 2Department of Gastroenterology, St Ivan Rilski Hospital, Bulgaria 3Department of Gastroenterology, Pediatric Hospital, Bulgaria 4Alexander Hospital, Second Surgery Hospital, Sofia, Bulgaria.
Nikolov
Rossen
R
Department of Microbiology, Medical University of Sofia, Zdrave Street 2, 1431 Sofia, Bulgaria 2Department of Gastroenterology, St Ivan Rilski Hospital, Bulgaria 3Department of Gastroenterology, Pediatric Hospital, Bulgaria 4Alexander Hospital, Second Surgery Hospital, Sofia, Bulgaria.
Derejian
Sirigan
S
Department of Microbiology, Medical University of Sofia, Zdrave Street 2, 1431 Sofia, Bulgaria 2Department of Gastroenterology, St Ivan Rilski Hospital, Bulgaria 3Department of Gastroenterology, Pediatric Hospital, Bulgaria 4Alexander Hospital, Second Surgery Hospital, Sofia, Bulgaria.
Lazarova
Elena
E
Department of Microbiology, Medical University of Sofia, Zdrave Street 2, 1431 Sofia, Bulgaria 2Department of Gastroenterology, St Ivan Rilski Hospital, Bulgaria 3Department of Gastroenterology, Pediatric Hospital, Bulgaria 4Alexander Hospital, Second Surgery Hospital, Sofia, Bulgaria.
Katsarov
Nikolai
N
Department of Microbiology, Medical University of Sofia, Zdrave Street 2, 1431 Sofia, Bulgaria 2Department of Gastroenterology, St Ivan Rilski Hospital, Bulgaria 3Department of Gastroenterology, Pediatric Hospital, Bulgaria 4Alexander Hospital, Second Surgery Hospital, Sofia, Bulgaria.
Mitov
Ivan
I
Department of Microbiology, Medical University of Sofia, Zdrave Street 2, 1431 Sofia, Bulgaria 2Department of Gastroenterology, St Ivan Rilski Hospital, Bulgaria 3Department of Gastroenterology, Pediatric Hospital, Bulgaria 4Alexander Hospital, Second Surgery Hospital, Sofia, Bulgaria.
Krastev
Zacharii
Z
Department of Microbiology, Medical University of Sofia, Zdrave Street 2, 1431 Sofia, Bulgaria 2Department of Gastroenterology, St Ivan Rilski Hospital, Bulgaria 3Department of Gastroenterology, Pediatric Hospital, Bulgaria 4Alexander Hospital, Second Surgery Hospital, Sofia, Bulgaria.
D000362:Agar; D000890:Anti-Infective Agents / Q000494:pharmacology*; D003470:Culture Media; D004305:Dose-Response Relationship, Drug; D000431:Ethanol; D016480:Helicobacter pylori / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D011429:Propolis / Q000494:pharmacology*
D000890:Anti-Infective Agents; D003470:Culture Media; D000431:Ethanol; D000362:Agar; D011429:Propolis